ThermoGenesis Corp. to Announce Third Quarter Fiscal 2009 Results on M... ( RANCHO CORDOVA Calif. April 30 Fi...)

ThermoGenesis Corp. to Announce Third Quarter Fiscal 2009 Results on May 6, 2009

Date:4/30/2009

RANCHO CORDOVA, Calif., April 30 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products that process and store adult stem cells, announced today it will report financial results for the fiscal third quarter ended March 31, 2009, on Wednesday, May 6, 2009.

Company's Conference Call and Webcast

Management will host a conference call Wednesday, May 6, 2009 at 2:00 PM Pacific (5:00 PM Eastern) to review the fiscal third quarter financial results.

The call can be accessed by dialing 1-800-860-2442 within the U.S. or 1-412-858-4600 outside the U.S. and referencing, "ThermoGenesis." Mr. J. Melville Engle, Chief Executive Officer and Mr. Matthew Plavan, Executive Vice President, Chief Operating Officer and Chief Financial Officer will host the call to discuss the third quarter results and other corporate events, followed by a Q&A session. Participants are asked to call the assigned number approximately 5 minutes before the conference call begins.

To listen to the audio webcast of the call during or after the event, please visit: http://www.thermogenesis.com/investors-webcasts-and-calls.aspx.

Replay

A replay of the conference call will be available two hours after the call for the following five business days by dialing 1-877-344-7529 within the U.S. or 1-412-317-0088 outside the U.S. and entering the following account number when prompted '385107'.

About ThermoGenesis Corp.

ThermoGenesis Corp. (

SOURCE ThermoGenesis Corp.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
2. ThermoGenesis Corp. Reports First Quarter 2008 Results
3. Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
4. ThermoGenesis Announces Filing of 510(k) Application for MarrowXpress
5. ThermoGenesis Announces 10 New BioArchive(R) System Distributors
6. ThermoGenesis Reports First Quarter 2009 Results
7. ThermoGenesis Announces Management Transition; Provides Update on Operational Milestones
8. ThermoGenesis Corp. Schedules Conference Call/Webcast to Discuss Management Transition
9. ThermoGenesis Corp. Provides Updated Information for Conference Call/Webcast to Discuss Management Transition
10. ThermoGenesis Introduces New Cell Separation Technology for Veterinary Use at Major Equine Convention
11. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone

Post Your Comments:

(Date:12/2/2009)...ewswire/ -- Reportlinker.com announces that a new ...ue: ,, Antibiotic Resistance and Antibiotic Te...rtlinker.com/p0166825/Antibiotic-Resistance-and-An...rovide an in-depth review of the global market for...es ,, Offer an analysis of antibiotics resistan...

(Date:12/2/2009)...re-USNewswire/ -- ,, Statement by John Gay, Ex...tion ,, In response to a new campaign launche...educate consumers and rid the marketplace of "rogu...ts, the Natural Products Association, the oldest a...s and manufacturers of dietary supplements and oth...

(Date:12/2/2009)...ses, study finds , , WEDNESDAY, Dec. 2 (...al rates for advanced lung cancer patients in the ...has found. , Researchers analyzed data on more ...mall cell lung cancer (NSCLC) between 1990 and 200...l Cancer Institute,s Surveillance, Epidemiology an...

(Date:12/2/2009)... could counter recent increases in longevity , ... overall health of the U.S. population has improve...ple have quit smoking in droves, but a new study s... rising obesity rates among Americans don,t level ...g and obesity continue unchanged, the average life...

(Date:12/2/2009)...olic syndrome, study finds , , WEDNESDAY...enough to keep overweight college football players... that can lead to heart disease, a new study sugge...I colleges and found that two-thirds were obese. O...p of conditions that raise the risk for heart dise...

[0] Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets [0] Natural Products Association Issues Statement on New Supplement Safety Campaign [0] Gains Made in Lung Cancer Survival [0] Health Gains From Lowered Smoking Rates in Jeopardy [0] Oversized College Football Players May Face Heart Risks

...st common in-flight medical emergency. Research re...ournal Critical Care details the number, type an...rlines. , Michael Sand led a team of researchers ...ough in-flight medical emergencies are rare in gen...

...mily Faces Same Decision as Millions: How to Care ...le Obama,s mother, Marian Robinson, moves into the...prightly mother, Jean, is in for some life changes... Washington, D.C. to take on the demanding job of ...

..., Week to be observed Jan. 25 - 31 , , HARRIS...have made quitting smoking a personal goal for 200... limited number of free nicotine replacement thera... before being successful, and those who have suppo...

...alian and international scientists will gather in ...Neuroscience Society (ANS) meeting. It marks a hom...a meeting in Canberra in 1980, with substantial in...e, revealing the latest discoveries in brain and n...

...DON, Jan. 23 Schofield Healthcare Media Ltd,(SHML...nced on the 16th,January that it has acquired Medi... set up by Jane Jones in 1997 as the publishing an...alising in effective,targeted and intelligent medi...

...ar 2008 Revenue of Approximately $250 Million , ,... Million to $350 Million , , SAN DIEGO, Jan. 23 ... company focused on developing products for minima...d provided financial guidance for the full year 20...

Other Medicine News:Health News:Research identifies in-flight emergencies 2 Health News:Change for the Country = Change for the Bidens 2 Health News:Change for the Country = Change for the Bidens 3 Health News:Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2 2 Health News:The world's best brains descend on Canberra 2 Health News:Further Acquisition for (London Based) Schofield Healthcare Media 2 Health News:NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results 2 Health News:NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results 3 Health News:NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results 4

Research identifies in-flight emergencies Change for the Country = Change for the Bidens Pennsylvania to Offer Free Nicotine Replacement Therapy Kits Beginning Feb. 2 The world's best brains descend on Canberra Further Acquisition for (London Based) Schofield Healthcare Media NuVasive Announces Preliminary Unaudited Full Year 2008 Financial Results

(Date:12/2/2009)...W YORK, Dec. 2 Interleuk...ne Medical Center announced findings from a study ... the genetics of osteoarthritis have been publishe...nnals of Rheumatic Diseases and is available at h...df . Results from the study highlight importan...

(Date:12/2/2009)... 2 Decision Resources, one of the ...armaceutical and healthcare issues, finds that gen...al antipsychotics will cause the schizophrenia dru...$5.2 billion in 2013 in the United States, France,...an. ,, The new Pharmacor report entitled Schiz...

(Date:12/2/2009)...Newswire-FirstCall/ -- Keryx Biopharmaceuticals, I... Food and Drug Administration (FDA) has granted Fa...e Company,s novel, potentially first-in-class, ora...tide 3-kinase (PI3K)/Akt pathway, for the treatmen... The Fast Track program of the FDA is designed to ...

Breaking Medicine Technology:Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 2 Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 3 Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis 4 Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 2 Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 2 Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 3 Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma 4 M TEC Announces Leadership Changes and a Commitment to Serving as Innovators in the Medical Transcription Industrys Evolution 55528 1 M TEC Announces Leadership Changes and a Commitment to Serving as Innovators in the Medical Transcription Industrys Evolution 55528 2 M TEC Announces Leadership Changes and a Commitment to Serving as Innovators in the Medical Transcription Industrys Evolution 55528 3 CMSA Announces New Model ACT Supporting Case Management Programs 55526 1 CMSA Announces New Model ACT Supporting Case Management Programs 55526 2 CMSA Announces New Model ACT Supporting Case Management Programs 55526 3 President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 1 President Bill Clinton to Speak at Inaugural Chicago House Speaker Series Luncheon 55524 2

[0] Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of Osteoarthritis [0] Generic Erosion of Established Branded Atypical Antipsychotics Will Cause the Schizophrenia Drug Market To Decline More Than $1 Billion by 2013 [0] Keryx Receives FDA Fast Track Designation for KRX-0401 (Perifosine) for the Treatment of Relapsed/Refractory Multiple Myeloma

... - Team Type 1, - Spreads...rs Toward Its Ultimate Goal of Tour d... 2008 ,Sanofi-aventis announced today its rapid-ac...igin] injection) will now become the primary spons...nal cyclists living with type 1,diabetes., "Team ...

...Italy, April 2 , - Presentation of Phase IIa Effi...obal independent biopharmaceutical,development spe...rticularly,oncology and cardiology, and sigma-tau ... leading Italian pharmaceutical group, today prese...zon-HF study with Debio 0614,(formerly PST2744), a...

Other Medicine Technology:Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 2 Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 3 Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 4 Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R) 5 Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure 2 Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure 3

Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)Clinical Update - Debio 0614 (Istaroxime) in Acute Heart Failure

2.5V Ophthalmic BETA 200 Pro

Welch Allyn PanOptic Ophthalmoscope

RT-600

Illuminated Phoroptor

Medicine Products:

2.5V Ophthalmic BETA 200 Pro Welch Allyn PanOptic Ophthalmoscope RT-600 Illuminated Phoroptor

ThermoGenesis Corp. to Announce Third Quarter Fiscal 2009 Results on M...( RANCHO CORDOVA Calif. April 30 Fi...),Health